Article
DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility.
Aging - 5 Dec 2024
Jung Su Yon, Yu Herbert, Deng Youping, Pellegrini Matteo
Abstract excerpt
BACKGROUND: DNA methylation (DNAm)-based marker of aging, referred to as 'epigenetic age' or 'DNAm age' is a highly accurate multi-tissue biomarker for aging, associated with age-related disease risk, including cancer. Breast cancer (BC), an age-associated disease, is associated with older DNAm age and epigenetic age acceleration (age accel) at tissue levels. But this raises a question on the predictability of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
